Search research articles
Contact Us
Filters
Showing results (161-170 of 322) with videos related to
Page
of 33
Sort By:
The Neurologist
|
June 14, 2003
Approved and future pharmacotherapy for multiple sclerosis
Olaf Stüve, Bruce C Cree, Hans-Christian von Büdingen, et al.
JAMA Neurology
|
June 9, 2020
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
Ludwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, et al.
The Journal of Experimental Medicine
|
June 26, 2013
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity
Ulf Schulze-Topphoff, Simona Casazza, Michel Varrin-Doyer, et al.
Brain : a Journal of Neurology
|
September 10, 2019
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis
Colm Elliott, Shibeshih Belachew, Jerry S Wolinsky, et al.
Journal of Medical Internet Research
|
February 15, 2022
Building a Precision Medicine Delivery Platform for Clinics: The University of California, San Francisco, BRIDGE Experience
Riley Bove, Erica Schleimer, Paul Sukhanov, et al.
Journal of Neurology
|
March 2, 2019
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
Benjamin Turner, Bruce A C Cree, Ludwig Kappos, et al.
Brain : a Journal of Neurology
|
February 16, 2013
A genome-wide association study of brain lesion distribution in multiple sclerosis
Pierre-Antoine Gourraud, Michael Sdika, Pouya Khankhanian, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 9, 2014
2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times
Nico Papinutto, Regina Schlaeger, Valentina Panara, et al.
Journal of Neurology
|
December 5, 2022
Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis
Marco Ganzetti, Jennifer S Graves, Sven P Holm, et al.
Multiple Sclerosis and Related Disorders
|
December 11, 2025
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis
Stephen L Hauser, Mark S Freedman, Jin Nakahara, et al.
Page
of 33
Search research articles
Search
Showing results (161-170 of 322) with videos related to
Sort By:
Page
of 33
The Neurologist
|
June 14, 2003
Approved and future pharmacotherapy for multiple sclerosis
Olaf Stüve, Bruce C Cree, Hans-Christian von Büdingen, et al.
JAMA Neurology
|
June 9, 2020
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
Ludwig Kappos, Jerry S Wolinsky, Gavin Giovannoni, et al.
The Journal of Experimental Medicine
|
June 26, 2013
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity
Ulf Schulze-Topphoff, Simona Casazza, Michel Varrin-Doyer, et al.
Brain : a Journal of Neurology
|
September 10, 2019
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis
Colm Elliott, Shibeshih Belachew, Jerry S Wolinsky, et al.
Journal of Medical Internet Research
|
February 15, 2022
Building a Precision Medicine Delivery Platform for Clinics: The University of California, San Francisco, BRIDGE Experience
Riley Bove, Erica Schleimer, Paul Sukhanov, et al.
Journal of Neurology
|
March 2, 2019
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
Benjamin Turner, Bruce A C Cree, Ludwig Kappos, et al.
Brain : a Journal of Neurology
|
February 16, 2013
A genome-wide association study of brain lesion distribution in multiple sclerosis
Pierre-Antoine Gourraud, Michael Sdika, Pouya Khankhanian, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 9, 2014
2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times
Nico Papinutto, Regina Schlaeger, Valentina Panara, et al.
Journal of Neurology
|
December 5, 2022
Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis
Marco Ganzetti, Jennifer S Graves, Sven P Holm, et al.
Multiple Sclerosis and Related Disorders
|
December 11, 2025
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis
Stephen L Hauser, Mark S Freedman, Jin Nakahara, et al.
Page
of 33